Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Hyperion Therapeutics 

601 Gateway Boulevard
Suite 200
San Francisco  California  94080  U.S.A.
Phone: 650-745-7802 or 1-888-897-4276 Fax: 650-871-7029


 Company News
Hyperion Therapeutics Appoints Theodore Schroeder To Board Of Directors 8/12/2014 3:25:05 PM
Hyperion Therapeutics Announces Second Quarter 2014 Financial Results 8/8/2014 9:24:44 AM
Hyperion Therapeutics To Present At The 2014 Wedbush Life Sciences Conference 8/7/2014 9:21:37 AM
Hyperion Therapeutics To Report Second Quarter 2014 Financial Results After Market On August, 7, 2014 8/4/2014 8:27:14 AM
Hyperion Therapeutics Announces European Medicines Agency Acceptance For Review Of Marketing Authorization Application For RAVICTI® 6/26/2014 7:38:51 AM
Hyperion Therapeutics To Present At The JMP Healthcare Conference 6/19/2014 8:32:43 AM
Hyperion Therapeutics To Present At 2014 Wells Fargo Healthcare Conference 6/13/2014 7:56:10 AM
Hyperion Therapeutics Completes Acquisition Of Andromeda Biotech 6/12/2014 7:20:13 AM
Hyperion Therapeutics Announces Health Canada Accepts RAVICTI® New Drug Submission With Priority Review 6/3/2014 9:16:56 AM
Hyperion Therapeutics To Present At Jefferies and Co. 2014 Global Healthcare Conference 5/29/2014 9:36:13 AM